Next Article in Journal
Design and Validation of a Questionnaire on Communicating Bad News in Nursing: A Pilot Study
Next Article in Special Issue
New Intravenous Calcimimetic Agents: New Options, New Problems. An Example on How Clinical, Economical and Ethical Considerations Affect Choice of Treatment
Previous Article in Journal
Objective and Subjective Dementia Caregiving Burden: The Moderating Role of Immanent Justice Reasoning and Social Support
Previous Article in Special Issue
Medication Adherence, Burden and Health-Related Quality of Life in Adults with Predialysis Chronic Kidney Disease: A Prospective Cohort Study
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Prevalence of Chronic Kidney Disease in Cuttack District of Odisha, India

by
Nisith Kumar Mohanty
1,
Krushna Chandra Sahoo
2,*,
Sanghamitra Pati
2,
Asish K. Sahu
1 and
Reena Mohanty
3
1
Utkal Kidney Foundation, Apollo Hospitals, Bhubaneswar 751005, Odisha, India
2
Regional Medical Research Centre, Indian Council of Medical Research, Bhubaneswar 751023, Odisha, India
3
Capital Hospital, Bhubaneswar 751001, Odisha, India
*
Author to whom correspondence should be addressed.
Int. J. Environ. Res. Public Health 2020, 17(2), 456; https://doi.org/10.3390/ijerph17020456
Submission received: 13 August 2019 / Revised: 29 October 2019 / Accepted: 25 November 2019 / Published: 10 January 2020
(This article belongs to the Special Issue Chronic Kidney Disease)

Abstract

:
Chronic kidney disease is one of the major health challenges in India. Cuttack district of the Odisha state of India is regarded as a hotspot for chronic kidney disease (CKD). However, there is limited information on true prevalence. This study estimates the prevalence of CKD in the Narsinghpur block of Cuttack district, Odisha. A cross-sectional study was conducted among population members aged 20–60 years. Using a multi-stage cluster sampling. 24 villages were randomly selected for mass screening for CKD. Blood samples were collected and glomerulus filtration rates were calculated. It was found that among the 2978 people screened, 14.3% were diagnosed with CKD and 10.8% were diagnosed with CKD without either diabetes or hypertension. In one-third of the sampled villages, about 20% population was diagnosed with CKD. The prevalence was higher among males (57%), in the population below 50 years of age (54%), lower socioeconomic groups (70%), and agricultural occupational groups (48%). Groundwater tube wells (49%) and wells (41%) were the main drinking water sources for CKD patients. This study highlights the need for detection of unknown etiologies of CKD and public health interventions for the prevention of CKD in India.

1. Introduction

Chronic kidney disease (CKD) is defined as kidney damage with a glomerular filtration rate (GFR) < 60 mL/min/1.73 m2 for three months or more, irrespective of the cause. Kidney damage in many kidney diseases can be ascertained by the presence of albuminuria, defined as an albumin–creatinine ratio >30 mg/g in two of three spot urine specimens [1]. It affects the kidney structure, reduces the glomerular filtration rate, and increases albumin excretion in urine [1,2]. It is one of the rising public health issues worldwide [3,4,5]. The global prevalence of CKD is 8%–16% and is the twelfth most common reason for mortality [3,6,7]. The consequences of CKD are increased cardiovascular disease, premature-mortality, and degraded quality of life [2]. Globally, 80% of CKD related deaths occur in developing countries [8,9,10]. However, there is a lack of kidney registries in many developing countries and it is a challenge to estimate the true prevalence of CKD in these countries [8,9,10]. In developing countries, the majority of patients died because of the unaffordability of high cost treatments [5,11,12].
CKD is one of the foremost public health concerns in Southeast Asia [12,13]. However, the true incidence and prevalence in these regions are lacking. Most of the affected population are younger and in their productive years of life [12,14]. Similarly, in India, CKD is one of the common non-communicable diseases and results in high morbidity, mortality, and economic burden [3,15]. In India, the number of CKD related mortalities was about 5.2 million in 2008 and may rise to 7.63 million by 2020 [16]. Hot-spots of CKD have been reported in a few states—India-Puducherry, Andhra Pradesh, Maharashtra, and Odisha [15]. However, in India, accurate prevalence and incidence data of CKD is lacking [8,17,18] as there are hardly any community-based studies [15].
In Odisha, Cuttack district is regarded as a hotspot for CKD. According to hospital records, more than 2000 cases have been identified during the last five years, of which nearly 25% died. However, all reported cases were based on hospital records. There is limited information on the true prevalence of CKD in Odisha. Therefore, this study estimated the prevalence of CKD in Narsinghpur, Cuttack, Odisha, India.

2. Materials and Methods

2.1. Study Design and Settings

Cross-sectional epidemiological research was conducted to estimate the actual prevalence of CKD in the Narsinghpur block of Cuttack, Odisha. There are 25 administrative blocks in Cuttack district with a total population of 2.62 million. The Narsinghpur block has 157 villages and a population of about 98,000, with around 58,000 people between 20–60 years of age. There was a representative sample of the general population in this study. The study included male and female members of the population in the 20–60 years of age group.

2.2. Sample Size, Sampling, and Study Variables

The required sample size for this study was calculated using Epi Info software. According to Varma in India, the prevalence of CKD is 6.3% among the younger population, even those with low prevalence of diabetes [9]. The required sample size was 2268 with an estimated proportion of 6.3%, a confidence level 95%, and a desired precision of 0.01.
The sample was collected using a multi-stage cluster method. The universe of the study was the population of 20–60-year-olds in the Narsinghpur block (n = 58,574), distributed across 157 villages. In order to achieve the required number of samples, 24 villages were randomly chosen from 157 villages. The socio-demographic profile, occupational history of the participants, information on CKD history, and other chronic illnesses were collected. The weight and height of the participants were measured for the calculation of Body Mass Index (BMI).

2.3. Collection and Analysis of a Clinical Sample

The clinical measurements included blood pressure, random blood sugar, urine protein and sugar, and serum creatinine. Hypertension is defined as a systolic BP ≥ 140 mmHg or diastolic BP ≥ 90 mmHg. A random blood glucose level of 200 mg/dL or more, with the presence of symptoms such as increased urination as well as thirst and unexplained weight loss, were considered as evidence of the individual having diabetes. Urine was collected in a transparent plastic container and tested immediately using a dipstick to test protein and sugar (Catalog No. 2161; MultiStix 10SG, Urine Dipstick, 100 strips per package, Bayer).
To process the test, 7.5 mL of blood was collected by trained professionals. The samples were processed and the biochemical test was performed using standard protocol at GenX Diagnostics, Bhubaneswar, which is certified by the National Accreditation Board for Testing and Calibration Laboratories. The creatinine was tested using the enzymatic method and glucose by the hexokinase method. The Glomerular Filtration Rate (GFR) was calculated with the help of the Modification of Diet in Renal Disease formula, Primary Care Informatics, London, United Kingdom. The CKD stages were estimated using the National Kidney Foundation Kidney Disease Outcomes Quality Initiative guidelines [19].

2.4. Statistical Analysis

The data were entered into Microsoft Excel and then transferred to Stata 10.1 (Stata Corp. College Station, TX, USA) software for statistical analysis. Categorical variables were expressed in terms of frequencies (n) and percentages (%). The quantitative variables were expressed through mean and standard deviation (SD). The characteristics of the screening population and prevalence of CKD were presented in the table. The prevalence of various stages of CKD was presented using a bar diagram. Differences in prevalence were assessed by a chi-square test and p < 0.05 was considered statistically significant.

2.5. Ethical Considerations

The Institutional Review Board of Apollo Hospitals, Bhubaneswar approved this study. Written consent was obtained from all participants for the collection of information and clinical samples.

3. Results

A total of 2616 households in 24 villages were surveyed. Out of 11,481 individuals, 6581 were in the age group of 20–60 years. Of these, 1970 were staying outside of the village and 478 were absent during the survey. Hence, the target population for screening was 4133 individuals. However 1155 were unwilling to participate in this study and a total 2978 individuals participated in this study.
Among 2978 individuals, 349 (11.7%) had hypertension, 169 (5.7%) had diabetes, 459 (15.4%) were either diabetic or had hypertension, and only 59 (1.98%) had both diabetes and hypertension.
Out of the screened population of 2978, 426 (14.3%) were diagnosed with CKD. Among them, a total of 323 (10.8%) were diagnosed with CKD without diabetes or hypertension and 103 (3.5%) had CKD with either diabetes or hypertension. Only 18 individuals had CKD with both diabetes and hypertension. The meanS.D) value of serum creatinine in CKD patients with either diabetes or hypertension (n = 103) was observed to be 157.06 ± 98.41, whereas in CKD patients without diabetes or hypertension (n = 323) it was 171.67 ± 135.35. Similarly, the meanS.D) value of GFR in CKD patients with either diabetes or hypertension (n = 103) was observed to be 50.7 ± 25.27, whereas in CKD patients without diabetes or hypertension (n = 323) it was 50.81 ± 27.2. In Table 1 the characteristics of the screening population and prevalence of CKD are presented.
The results show that the prevalence of CKD is higher among females (53%) in comparison to males (47%). However, the occurrence of CKD in patients without diabetes or hypertension is higher among males (57%) than females (43%). Among the patients having CKD without diabetes or hypertension, more than half (54%) of them were below 50 years of age. However, in cases of CKD with either diabetes or hypertension, 57% were above 50 years of age.
It was found that among the patients having CKD without diabetes or hypertension, 46% belonged to other backward classes and 28% to scheduled castes. A majority of them belonged to sub-caste chase/sudra (18%), khandayat (19%), and kaibarta (15%). Around 26% had an agricultural occupation and 22% were agricultural laborers. Around 70% belonged to the lower socioeconomic group. The main drinking water sources were groundwater, such as from tube-wells (49%) and wells (41%). Among patients, 76% never consumed alcohol. In the villages studied, one-third of the villages and about 20% of the population were diagnosed with CKD without diabetes or hypertension.
In Figure 1 the prevalence of various stages of CKD with either diabetes or hypertension and without diabetes or hypertension is presented. It was found that among the patients who had CKD without diabetes or hypertension, the prevalence was stages I (22.6%), III (54.2%), IV (16.7%), and V (6.5%).

4. Discussion

In India, there is a paucity of data in the national registry on the incidence and prevalence of CKD [8,17,18]. Hence, the accurate burden of CKD in India is lacking. The approximate prevalence is around 800 per million population and the incidence of end-stage renal failure cases is about 200 per million population [20]. In our study total, 14.3% were diagnosed CKD and the prevalence of CKD without diabetes or hypertension was 10.8%. In India, a previous community-based screening showed about 17.2% of CKD cases [21]. A study conducted among 52,273 adults showed rates of CKD diagnosis in South India (36%), North India (28%), West India (26%), and East India (11%) [17].
The prevalence of various stages of CKD in our study was stages I (22.6%), III (54.2%), IV (16.7%), and V (6.5%). However, a study conducted among Indian central government employees over 18 years of age showed that about 6.6% had stage I, 5.4% stage II, and 3% stage III CKD [18]. Similarly, a community-based screening study in India (n = 6120) found that the prevalence of CKD in stages I (7%), II and III (4.3%), and IV and V (0.8%) [21]. Hypertension and diabetes were key risk factors for CKD and hypertension was the commonly occurring co-morbidity among CKD patients (49%) [18,19,20,21,22]. Being hypertensive puts an individual more at-risk for CKD. In India, diabetes and hypertension today account for 40%–60% of cases of CKD [23]. Singh NP et.al., reported that hypertension was associated with low GFR [20]. Even though hypertension is associated with CKD of unknown origin, because of the study nature we cannot establish temporal association. Additionally, studies have found that high blood pressure is common in CKD patients and might have created a biased result.
The worldwide prevalence of CKD is 11%–13% [3,23] with age-standardized prevalence among the 20 years and above population occurring in 10.4% of males and 11.8% of females [24]. In developing countries, the prevalence is 10.6% female and 12.5% male. However, in developed nations 8.6% of males and 9.6% of females are living with CKD [24]. According to a nationally representative sample survey, in China the CKD prevalence among adults is 10.8% [13]. In sub-Saharan Africa, there were poor data quality limits inferences for evidence [10]. The CKD prevalence by stages was stage I (3·5%), stage II (3·9%), stage III (7·6%), stage IV (0·4%), and stage V (0·1%) [3]. Hypertension (48.7%) and diabetes (17.4%) were the most common comorbidities for CKD [25]. The prevalence of end-stage renal failure was about 0.27%. According to MDRD, the prevalence of CKD was around 4% [25] and CKD of undetermined etiology at 16% [17].
In recent years, a number of CKD cases without diabetes or hypertension have been reported in several Central American countries, El-Minia Governorate in Egypt, Sri Lanka, particularly in the North Central Province, and Andhra Pradesh, India [2,14,26,27,28]. A community screening in Sri Lanka found that the prevalence of CKD of unknown origin among those above 18 years of age was around 3% [29]. In Sri Lanka, it was found that the prevalence of CKD of unknown origin among males was 13% and females 17%. The risk was higher among the population above 40 years of age [14]. In our findings, the CKD of unknown origin was found more among males (57%), the population below 50 years of age (54%), members of the lower socioeconomic group (70%), and among farmer and agricultural labor (48%). Similarly, in Central America the CKD of unknown origin is found among adult males whose occupation was agriculture, particularly those who were working in sugarcane fields [27]. In our study, groundwater tube-well (49%) and well (41%) water were the main drinking water sources for patients with CKD of unknown origin. The studies revealed that the drinking water might be a risk factor for CKD of unknown origin and the inorganic chemicals in groundwater cause CKD of unknown origin [26,28]. The studies show that patients with CKD of unknown origin are young, poor, and dependent on public hospitals for treatment [17,28,29,30,31], which is similar to our findings.
In many developing countries, CKD is one of the major disease burdens. Hence, it is urgent to understand the epidemiology of CKD [9,10,30,31] and it is important to characterize the responsible factors in order to prevent the disease [12]. In India, the prevention of CKD might be one of the priorities in the planning and implementation of non-communicable disease prevention policy [7]. The management of chronic diseases requires comprehensive, cost-effective, and preventative interventions [11]. There is a critical need for research and interventions to reduce the burdens of CKD in India [5]. The treatment of CKD, especially end-stage renal disease is very expensive. Furthermore, in rural settings management is challenging due to a lack of health care services [31]. There is a lack of trained nephrologists, hence, primary, secondary, and tertiary measures for prevention are significant [29,31] to preventing CKD.
The limitations of this study were that although the target population for screening of CKD was 4133 from 24 sampled villages, 1155 (27.9%) were unwilling to take part in screening because of fear and stigma. Furthermore, this study did not identify etiological factors, as the true prevalence data are lacking and this study focused on the prevalence of CKD.

5. Conclusions

This study indicates that early recognition through community screening, awareness-raising among community members, and educating healthcare workers on identifying risk populations is necessary. There is also a need for further research on the etiology of CKD of unknown origin and challenges in healthcare among patients.

Author Contributions

Conceptualization, methodology, software, validation K.C.S., N.K.M., A.K.S., S.P.; formal analysis, data curation, draft preparation, K.C.S.; investigation, review, editing, visualization, supervision, K.C.S., N.K.M., S.P., A.K.S., R.M.; project administration, funding acquisition, A.K.S.; resources, N.K.M. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Acknowledgments

We acknowledge our study participants for their participation, field staff for data collection, and laboratory staff for clinical investigations. The authors also acknowledge Model Rural Health Research Unit, ICMR-Regional Medical Research Centre for supporting this study.

Conflicts of Interest

We declare no conflict of interest.

References

  1. Levey, A.S.; Eckardt, K.U.; Tsukamoto, Y.; Levin, A.; Coresh, J.; Rossert, J.; Zeeuw, D.D.; Hostetter, T.H.; Lameire, N.; Eknoyan, G. Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2005, 67, 2089–2100. [Google Scholar] [CrossRef] [Green Version]
  2. Webster, A.C.; Nagler, E.V.; Morton, R.L.; Masson, P. Chronic kidney disease. Lancet 2017, 389, 1238–1252. [Google Scholar] [CrossRef]
  3. Hill, N.R.; Fatoba, S.T.; Oke, J.L.; Hirst, J.A.; O’Callaghan, C.A.; Lasserson, D.S.; Hobbs, F.R. Global prevalence of chronic kidney disease–a systematic review and meta-analysis. PLoS ONE 2016, 11, e0158765. [Google Scholar] [CrossRef]
  4. Weaver, V.M.; Fadrowski, J.J.; Jaar, B.G. Global dimensions of chronic kidney disease of unknown etiology (CKDu): A modern era environmental and/or occupational nephropathy? BMC Nephrol. 2015, 16, 145. [Google Scholar] [CrossRef] [Green Version]
  5. Ayodele, O.E.; Alebiosu, C.O. Burden of chronic kidney disease: An international perspective. Adv. Chronic Kidney Dis. 2010, 17, 215–224. [Google Scholar] [CrossRef]
  6. Patel, M.L.; Sachan, R.; Misra, R.; Kamal, R.; Shyam, R.; Sachan, P. Prognostic significance of urinary NGAL in chronic kidney disease. Int. J. Nephrol. Renov. Dis. 2015, 8, 139. [Google Scholar] [CrossRef] [Green Version]
  7. Couser, W.G.; Remuzzi, G.; Mendis, S.; Tonelli, M. The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. Kidney Int. 2011, 80, 1258–1270. [Google Scholar] [CrossRef] [Green Version]
  8. Stanifer, J.W.; Muiru, A.; Jafar, T.H.; Patel, U.D. Chronic kidney disease in low-and middle-income countries. Nephrol. Dial. Transplant. 2016, 31, 868–874. [Google Scholar] [CrossRef] [Green Version]
  9. Varma, P.P. Prevalence of chronic kidney disease in India-Where are we heading? Indian J. Nephrol. 2015, 25, 133. [Google Scholar]
  10. Stanifer, J.W.; Jing, B.; Tolan, S.; Helmke, N.; Mukerjee, R.; Naicker, S.; Patel, U. The epidemiology of chronic kidney disease in sub-Saharan Africa: A systematic review and meta-analysis. Lancet Glob. Health 2014, 2, 174–181. [Google Scholar] [CrossRef] [Green Version]
  11. Nugent, R.A.; Fathima, S.F.; Feigl, A.B.; Chyung, D. The burden of chronic kidney disease on developing nations: A 21st century challenge in global health. Nephron Clin. Pract. 2011, 118, 269–277. [Google Scholar] [CrossRef]
  12. Jha, V.; Saunders, W.B. (Eds.) Current status of chronic kidney disease care in southeast Asia. Semin. Nephrol. 2009, 29, 487–496. [Google Scholar] [CrossRef]
  13. Zhang, L.; Wang, F.; Wang, L.; Wang, W.; Liu, B.; Liu, J.; Chen, M.; He, Q.; Liao, Y.; Yu, X.; et al. Prevalence of chronic kidney disease in China: A cross-sectional survey. Lancet 2012, 379, 815–822. [Google Scholar] [CrossRef]
  14. Jayatilake, N.; Mendis, S.; Maheepala, P.; Mehta, F.R. Chronic kidney disease of uncertain aetiology: Prevalence and causative factors in a developing country. BMC Nephrol. 2013, 14, 180. [Google Scholar] [CrossRef] [Green Version]
  15. Jha, V.; Modi, G. Uncovering the rising kidney failure deaths in India. Lancet Glob. Health 2017, 5, 14–15. [Google Scholar] [CrossRef]
  16. Veerappan, I.; Abraham, G. Chronic kidney disease: Current status, challenges and management in India. Nephrology 2013, 130, 593–597. [Google Scholar]
  17. Rajapurkar, M.M.; John, G.T.; Kirpalani, A.L.; Abraham, G.; Agarwal, S.K.; Almeida, A.F.; Gang, S.; Gupta, A.; Modi, G.; Pahari, D.; et al. What do we know about chronic kidney disease in India: First report of the Indian CKD registry. BMC Nephrol. 2012, 13, 10. [Google Scholar] [CrossRef] [Green Version]
  18. Varma, P.P.; Raman, D.K.; Ramakrishnan, T.S.; Singh, P.; Varma, A. Prevalence of early stages of chronic kidney disease in apparently healthy central government employees in India. Nephrol. Dial. Transplant. 2010, 25, 3011–3017. [Google Scholar] [CrossRef] [Green Version]
  19. Levey, A.S. A decade after the KDOQI CKD guidelines. Am. J. Kidney Dis. 2012, 60, 683–685. [Google Scholar] [CrossRef]
  20. Agarwal, S.K.; Srivastava, R.K. Chronic kidney disease in India: Challenges and solutions. Nephron Clin. Pract. 2009, 111, 197–203. [Google Scholar] [CrossRef]
  21. Singh, A.K.; Farag, Y.M.; Mittal, B.V.; Subramanian, K.K.; Reddy, S.R.K.; Acharya, V.N.; Almeida, A.F.; Channakeshavamurthy, A.; Ballal, H.S.; Gaccione, P.; et al. Epidemiology and risk factors of chronic kidney disease in India–results from the SEEK (Screening and Early Evaluation of Kidney Disease) study. BMC Nephrol. 2013, 14, 114. [Google Scholar] [CrossRef] [Green Version]
  22. Anupama, Y.J.; Uma, G. Prevalence of chronic kidney disease among adults in a rural community in South India: Results from the kidney disease screening (KIDS) project. Indian J. Nephrol. 2014, 24, 214. [Google Scholar] [CrossRef]
  23. Jha, V. Current status of end-stage renal disease care in India and Pakistan. Kidney Int. Suppl. 2013, 3, 157–160. [Google Scholar] [CrossRef] [Green Version]
  24. Mills, K.T.; Xu, Y.; Zhang, W.; Bundy, J.D.; Chen, C.S.; Kelly, T.N.; Chen, J.; He, J. A systematic analysis of worldwide population-based data on the global burden of chronic kidney disease in 2010. Kidney Int. 2015, 88, 950–957. [Google Scholar] [CrossRef] [Green Version]
  25. Ahlawat, R.; Tiwari, P.; D’Cruz, S. Prevalence and predictors of medication non-adherence in patients of chronic kidney disease: Evidence from a cross-sectional study. J. Pharma Care Health Syst. 2016, 3, 2376-0419. [Google Scholar] [CrossRef] [Green Version]
  26. Jayasumana, C.; Paranagama, P.A.; Amarasinghe, M.D.; Wijewardane, K.M.R.C.; Dahanayake, K.S.; Fonseka, S.I.; Rajakaruna, K.D.L.M.P.; Mahamithawa, A.M.P.; Samarasinghe, U.D.; Senanayake, V.K. Possible link of chronic arsenic toxicity with chronic kidney disease of unknown etiology in Sri Lanka. J. Nat. Sci. Res. 2013, 3, 2224–3186. [Google Scholar]
  27. Correa-Rotter, R.; Wesseling, C.; Johnson, R.J. CKD of unknown origin in Central America: The case for a Mesoamerican nephropathy. Am. J. Kidney Dis. 2014, 63, 506–520. [Google Scholar] [CrossRef]
  28. Reddy, D.V.; Gunasekar, A. Chronic kidney disease in two coastal districts of Andhra Pradesh, India: Role of drinking water. Environ. Geochem. Health 2013, 35, 439–454. [Google Scholar] [CrossRef]
  29. Chandrajith, R.; Nanayakkara, S.; Itai, K.; Aturaliya, T.N.C.; Dissanayake, C.B.; Abeysekera, T.; Harada, K.; Watanabe, T.; Koizumi, A. Chronic kidney diseases of uncertain etiology (CKDue) in Sri Lanka: Geographic distribution and environmental implications. Environ. Geochem. Health 2011, 33, 267–278. [Google Scholar] [CrossRef]
  30. Jha, V.; Garcia-Garcia, G.; Iseki, K.; Li, Z.; Naicker, S.; Plattner, B.; Saran, R.; Wang, A.Y.M.; Yang, C.W. Chronic kidney disease: Global dimension and perspectives. Lancet 2013, 382, 260–272. [Google Scholar] [CrossRef]
  31. Liyanage, T.; Ninomiya, T.; Jha, V.; Neal, B.; Patrice, H.M.; Okpechi, I.; Zhao, M.H.; Lv, J.; Garg, A.X.; Knight, J.; et al. Worldwide access to treatment for end-stage kidney disease: A systematic review. Lancet 2015, 385, 1975–1982. [Google Scholar] [CrossRef]
Figure 1. Prevalence of various stages of chronic kidney diseases with either diabetes or hypertension and without diabetes or hypertension.
Figure 1. Prevalence of various stages of chronic kidney diseases with either diabetes or hypertension and without diabetes or hypertension.
Ijerph 17 00456 g001
Table 1. Characteristics of the screening population and prevalence of chronic kidney disease.
Table 1. Characteristics of the screening population and prevalence of chronic kidney disease.
Participants’ Characteristics Screening Population
(N = 2978)
Total CKD Cases
(N = 426)
CKD with Either Diabetes or Hypertension
(N = 103)
CKD without Diabetes or Hypertension
(N = 323)
n%n%n%Pn%P
Sex 0.044 <0.001
 Male111237.3231544847 18357
 Female186662.7195465553 14043
Age in years 0.001 <0.001
 20–3056418.922511 216
 31–4081027.2601499 5116
 41–5085228.6138333433 10432
 51–6075225.3206485957 14746
Education 0.683 <0.001
 Illiterate53217.9107252423 8326
 Primary school (1–5)98333.0170403433 13642
 Upper primary school (6 and 7)40213.545101414 3110
 High school (8–10)91030.688212726 6119
 Intermediate (11 and 12)752.59211 82
 Graduate (13 and above)762.57233 41
Marital status 0.264 <0.001
 Unmarried1876.37211 62
 Married 266289.4384909390 29190
 Widowed1294.335899 268
Caste 0.286 <0.001
 General60820.496222928 6721
 Other Backward Class (OBC)169656.9203485553 14846
 Scheduled Caste (SC) 60120.2107251717 9028
 Scheduled Tribe (ST)732.520522 185
Sub-caste 0.354 <0.001
 Badhei/Kumbhar1675.624677 175
 Bania/Teli/Rangani35611.93891514 237
 Bhandari953.27211 62
 Brahmin/Mali1013.415455 103
 Chamar/Kandar/Pana2357.937977 309
 Chasa/sudra62120.879182019 5918
 Dhoba280.95111 41
 Gopal31810.738966 3110
 Gudia682.311355 62
 Kaibarta31510.6551388 4715
 Kandha/Khaira732.420422 186
 Karana361.23133 00
 Khandayat51317.282192121 6119
 Tainla/Taira491.612311 113
Gotra 0.131 0.062
 Bachchas1013.419400 196
 Baghasya652.29211 82
 Bharadwaja511.79244 52
 Gajasya1866.210333 72
 Kachhapa1133.811355 62
 Nagasya201368.0299706967 23071
 Other 44914.769162120 4815
Occupation 0.065 <0.001
 Agriculture41614.0105252120 8426
 Government services752.516477 93
 Private services511.720.400 20.6
 Daily labor48916.485201515 7022
 Business1344.531788 237
 Homemakers 175659.0185435250 13341
 Student571.920.600 20.4
Socioeconomic status 0.590 0.007
 Lower181661.0284675654 22870
 Middle96832.5120283736 8326
 Upper1946.52251010 124
Main source of drinking water 0.786 0.176
 Tube-well130543.8203484443 15949
 Well 138846.618643.65250 13441
 Supply water2769.335877 289
 River90.320.400 21
Alcohol consumption 0.276 <0.001
 Never254385.4335798986 24676
 Desi liquor230.89222 72
 Foreign liquor 2578.6441055 3912
 Both desi and foreign liquor 1555.238977 3110
Smoking or chewing tobacco 0.179 0.076
 Never207269.6221526361 15849
 Occasionally smoke882.916411 154
 Regularly smoke1755.9501299 4113
 Smokeless tobacco64421.6139323029 10934
Body Mass Index (BMI) 0.758 0.066
 <18.52016.839955 3410
 18.5 to 25238180.0337798078 25780
 26 to 3033211.13991110 289
 >30642.111377 41
Family members diagnosed with CKD <0.001 <0.001
 Yes2036.884202120 6319
 No277593.2342808280 26081

Share and Cite

MDPI and ACS Style

Mohanty, N.K.; Sahoo, K.C.; Pati, S.; Sahu, A.K.; Mohanty, R. Prevalence of Chronic Kidney Disease in Cuttack District of Odisha, India. Int. J. Environ. Res. Public Health 2020, 17, 456. https://doi.org/10.3390/ijerph17020456

AMA Style

Mohanty NK, Sahoo KC, Pati S, Sahu AK, Mohanty R. Prevalence of Chronic Kidney Disease in Cuttack District of Odisha, India. International Journal of Environmental Research and Public Health. 2020; 17(2):456. https://doi.org/10.3390/ijerph17020456

Chicago/Turabian Style

Mohanty, Nisith Kumar, Krushna Chandra Sahoo, Sanghamitra Pati, Asish K. Sahu, and Reena Mohanty. 2020. "Prevalence of Chronic Kidney Disease in Cuttack District of Odisha, India" International Journal of Environmental Research and Public Health 17, no. 2: 456. https://doi.org/10.3390/ijerph17020456

APA Style

Mohanty, N. K., Sahoo, K. C., Pati, S., Sahu, A. K., & Mohanty, R. (2020). Prevalence of Chronic Kidney Disease in Cuttack District of Odisha, India. International Journal of Environmental Research and Public Health, 17(2), 456. https://doi.org/10.3390/ijerph17020456

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop